Balanced news tone
News Sentiment
600594 sentiment intelligence
Guizhou Yibai Pharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
62/100 classification confidence.
directly relevant articles
high-authority source matches
+2.1% over one week, +9.0% over four weeks, trend inactive, and near fair-value range.
Global Penny Stocks: Guizhou Yibai Pharmaceutical And 2 More To Watch
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Global Penny Stocks: Guizhou Yibai Pharmaceutical And 2 More To Watch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 09:15
- Source
- simplywall.st
Yibai Pharmaceutical reported revenue of 1.863 billion yuan in 2025, a year-on-year decrease of 14.31%. The company incurred a net loss attributable to shareholders of 330 million yuan, while the gross profit margin increased to 59.65%.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 00:37
- Source
- 富途牛牛
EBIT per share of Guizhou Yibai Pharmaceutical Co. Ltd. Class A – SSE:600594
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 14:10
- Source
- TradingView
Guizhou Yibai Pharmaceutical Co.,Ltd.’s Net Profit Dropped 26.9% in First Quarter of 2022
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 24 Apr 2022 07:00
- Source
- Caixin Global